Law360, New York (November 28, 2003, 12:00 AM EST) -- Eon Labs said Friday its introduction of a generic version of GlaxoSmithKline Plc's antidepressant Wellbutrin was delayed after GlaxoSmithKline won a temporary restraining order.
A U.S. judge entered an order which prevents Eon from offering for sale or selling 100 mg tablets of its generic Wellbutrin (bupropion HC1) until noon on Monday, Dec. 1, Eon said in a statement.
Eon earlier this week said it had received U.S. regulatory approval to market its drug and planned to begin shipping it immediately. The move marks the second...
Judge Blocks Generic Wellbutrin Until Monday
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login
